Report Detail

Request for Sample of this report

Pharma & Healthcare Global Targeting p53 Cancer Therapies Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4746916
    • |
  • 05 October, 2026
    • |
  • Global
    • |
  • 86 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Targeting p53 Cancer Therapies market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The essence of p53-targeted therapy is to regain the "tumor suppressor function" of the mutated p53 protein, or indirectly protect the "tumor suppressor function" of p53 by inhibiting other targets that can inhibit the wild-type p53 protein.
This report is a detailed and comprehensive analysis for global Targeting p53 Cancer Therapies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Targeting p53 Cancer Therapies market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Targeting p53 Cancer Therapies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Targeting p53 Cancer Therapies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Targeting p53 Cancer Therapies market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeting p53 Cancer Therapies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeting p53 Cancer Therapies market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sibiono GeneTech, Kartos Therapeutics, SynerGene Therapeutics, MultiVir, Rain Oncology, Alieron Therapeutics, Aprea Therapeutics, Ascentage Pharma, Jc (Wuxi) Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Targeting p53 Cancer Therapies market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Small Molecule Drugs
Immunotherapy
Gene Therapy
Others
Market segment by Application
Hospital
Clinic
Others
Major players covered
Sibiono GeneTech
Kartos Therapeutics
SynerGene Therapeutics
MultiVir
Rain Oncology
Alieron Therapeutics
Aprea Therapeutics
Ascentage Pharma
Jc (Wuxi) Company
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Targeting p53 Cancer Therapies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Targeting p53 Cancer Therapies, with price, sales quantity, revenue, and global market share of Targeting p53 Cancer Therapies from 2021 to 2026.
Chapter 3, the Targeting p53 Cancer Therapies competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeting p53 Cancer Therapies breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Targeting p53 Cancer Therapies market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Targeting p53 Cancer Therapies.
Chapter 14 and 15, to describe Targeting p53 Cancer Therapies sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Targeting p53 Cancer Therapies Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Small Molecule Drugs
    • 1.3.3 Immunotherapy
    • 1.3.4 Gene Therapy
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Targeting p53 Cancer Therapies Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Targeting p53 Cancer Therapies Market Size & Forecast
    • 1.5.1 Global Targeting p53 Cancer Therapies Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Targeting p53 Cancer Therapies Sales Quantity (2021-2032)
    • 1.5.3 Global Targeting p53 Cancer Therapies Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sibiono GeneTech
    • 2.1.1 Sibiono GeneTech Details
    • 2.1.2 Sibiono GeneTech Major Business
    • 2.1.3 Sibiono GeneTech Targeting p53 Cancer Therapies Product and Services
    • 2.1.4 Sibiono GeneTech Targeting p53 Cancer Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sibiono GeneTech Recent Developments/Updates
  • 2.2 Kartos Therapeutics
    • 2.2.1 Kartos Therapeutics Details
    • 2.2.2 Kartos Therapeutics Major Business
    • 2.2.3 Kartos Therapeutics Targeting p53 Cancer Therapies Product and Services
    • 2.2.4 Kartos Therapeutics Targeting p53 Cancer Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Kartos Therapeutics Recent Developments/Updates
  • 2.3 SynerGene Therapeutics
    • 2.3.1 SynerGene Therapeutics Details
    • 2.3.2 SynerGene Therapeutics Major Business
    • 2.3.3 SynerGene Therapeutics Targeting p53 Cancer Therapies Product and Services
    • 2.3.4 SynerGene Therapeutics Targeting p53 Cancer Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 SynerGene Therapeutics Recent Developments/Updates
  • 2.4 MultiVir
    • 2.4.1 MultiVir Details
    • 2.4.2 MultiVir Major Business
    • 2.4.3 MultiVir Targeting p53 Cancer Therapies Product and Services
    • 2.4.4 MultiVir Targeting p53 Cancer Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 MultiVir Recent Developments/Updates
  • 2.5 Rain Oncology
    • 2.5.1 Rain Oncology Details
    • 2.5.2 Rain Oncology Major Business
    • 2.5.3 Rain Oncology Targeting p53 Cancer Therapies Product and Services
    • 2.5.4 Rain Oncology Targeting p53 Cancer Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Rain Oncology Recent Developments/Updates
  • 2.6 Alieron Therapeutics
    • 2.6.1 Alieron Therapeutics Details
    • 2.6.2 Alieron Therapeutics Major Business
    • 2.6.3 Alieron Therapeutics Targeting p53 Cancer Therapies Product and Services
    • 2.6.4 Alieron Therapeutics Targeting p53 Cancer Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Alieron Therapeutics Recent Developments/Updates
  • 2.7 Aprea Therapeutics
    • 2.7.1 Aprea Therapeutics Details
    • 2.7.2 Aprea Therapeutics Major Business
    • 2.7.3 Aprea Therapeutics Targeting p53 Cancer Therapies Product and Services
    • 2.7.4 Aprea Therapeutics Targeting p53 Cancer Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Aprea Therapeutics Recent Developments/Updates
  • 2.8 Ascentage Pharma
    • 2.8.1 Ascentage Pharma Details
    • 2.8.2 Ascentage Pharma Major Business
    • 2.8.3 Ascentage Pharma Targeting p53 Cancer Therapies Product and Services
    • 2.8.4 Ascentage Pharma Targeting p53 Cancer Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Ascentage Pharma Recent Developments/Updates
  • 2.9 Jc (Wuxi) Company
    • 2.9.1 Jc (Wuxi) Company Details
    • 2.9.2 Jc (Wuxi) Company Major Business
    • 2.9.3 Jc (Wuxi) Company Targeting p53 Cancer Therapies Product and Services
    • 2.9.4 Jc (Wuxi) Company Targeting p53 Cancer Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Jc (Wuxi) Company Recent Developments/Updates

3 Competitive Environment: Targeting p53 Cancer Therapies by Manufacturer

  • 3.1 Global Targeting p53 Cancer Therapies Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Targeting p53 Cancer Therapies Revenue by Manufacturer (2021-2026)
  • 3.3 Global Targeting p53 Cancer Therapies Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Targeting p53 Cancer Therapies by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Targeting p53 Cancer Therapies Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Targeting p53 Cancer Therapies Manufacturer Market Share in 2025
  • 3.5 Targeting p53 Cancer Therapies Market: Overall Company Footprint Analysis
    • 3.5.1 Targeting p53 Cancer Therapies Market: Region Footprint
    • 3.5.2 Targeting p53 Cancer Therapies Market: Company Product Type Footprint
    • 3.5.3 Targeting p53 Cancer Therapies Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Targeting p53 Cancer Therapies Market Size by Region
    • 4.1.1 Global Targeting p53 Cancer Therapies Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Targeting p53 Cancer Therapies Consumption Value by Region (2021-2032)
    • 4.1.3 Global Targeting p53 Cancer Therapies Average Price by Region (2021-2032)
  • 4.2 North America Targeting p53 Cancer Therapies Consumption Value (2021-2032)
  • 4.3 Europe Targeting p53 Cancer Therapies Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Targeting p53 Cancer Therapies Consumption Value (2021-2032)
  • 4.5 South America Targeting p53 Cancer Therapies Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Targeting p53 Cancer Therapies Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Targeting p53 Cancer Therapies Sales Quantity by Type (2021-2032)
  • 5.2 Global Targeting p53 Cancer Therapies Consumption Value by Type (2021-2032)
  • 5.3 Global Targeting p53 Cancer Therapies Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Targeting p53 Cancer Therapies Sales Quantity by Application (2021-2032)
  • 6.2 Global Targeting p53 Cancer Therapies Consumption Value by Application (2021-2032)
  • 6.3 Global Targeting p53 Cancer Therapies Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Targeting p53 Cancer Therapies Sales Quantity by Type (2021-2032)
  • 7.2 North America Targeting p53 Cancer Therapies Sales Quantity by Application (2021-2032)
  • 7.3 North America Targeting p53 Cancer Therapies Market Size by Country
    • 7.3.1 North America Targeting p53 Cancer Therapies Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Targeting p53 Cancer Therapies Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Targeting p53 Cancer Therapies Sales Quantity by Type (2021-2032)
  • 8.2 Europe Targeting p53 Cancer Therapies Sales Quantity by Application (2021-2032)
  • 8.3 Europe Targeting p53 Cancer Therapies Market Size by Country
    • 8.3.1 Europe Targeting p53 Cancer Therapies Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Targeting p53 Cancer Therapies Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Targeting p53 Cancer Therapies Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Targeting p53 Cancer Therapies Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Targeting p53 Cancer Therapies Market Size by Region
    • 9.3.1 Asia-Pacific Targeting p53 Cancer Therapies Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Targeting p53 Cancer Therapies Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Targeting p53 Cancer Therapies Sales Quantity by Type (2021-2032)
  • 10.2 South America Targeting p53 Cancer Therapies Sales Quantity by Application (2021-2032)
  • 10.3 South America Targeting p53 Cancer Therapies Market Size by Country
    • 10.3.1 South America Targeting p53 Cancer Therapies Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Targeting p53 Cancer Therapies Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Targeting p53 Cancer Therapies Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Targeting p53 Cancer Therapies Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Targeting p53 Cancer Therapies Market Size by Country
    • 11.3.1 Middle East & Africa Targeting p53 Cancer Therapies Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Targeting p53 Cancer Therapies Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Targeting p53 Cancer Therapies Market Drivers
  • 12.2 Targeting p53 Cancer Therapies Market Restraints
  • 12.3 Targeting p53 Cancer Therapies Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Targeting p53 Cancer Therapies and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Targeting p53 Cancer Therapies
  • 13.3 Targeting p53 Cancer Therapies Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Targeting p53 Cancer Therapies Typical Distributors
  • 14.3 Targeting p53 Cancer Therapies Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Targeting p53 Cancer Therapies. Industry analysis & Market Report on Targeting p53 Cancer Therapies is a syndicated market report, published as Global Targeting p53 Cancer Therapies Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Targeting p53 Cancer Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo